196 related articles for article (PubMed ID: 37632203)
41. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
[TBL] [Abstract][Full Text] [Related]
42. Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection.
Pan Y; Tang W; Fan W; Zhang J; Chen X
Chem Soc Rev; 2022 Nov; 51(23):9759-9830. PubMed ID: 36354107
[TBL] [Abstract][Full Text] [Related]
43. Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation.
Buchwald ZS; Wynne J; Nasti TH; Zhu S; Mourad WF; Yan W; Gupta S; Khleif SN; Khan MK
Front Oncol; 2018; 8():612. PubMed ID: 30619752
[TBL] [Abstract][Full Text] [Related]
44. Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy.
D'Andrea MA; Reddy GK
Oncol Res Treat; 2023; 46(1-2):33-44. PubMed ID: 36349774
[TBL] [Abstract][Full Text] [Related]
45. Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report.
Fiorica F; Belluomini L; Giuliani J; Urbini B; Milella M; Frassoldati A; Pilotto S; Giorgi C
Immunotherapy; 2021 Aug; 13(12):971-976. PubMed ID: 34180714
[TBL] [Abstract][Full Text] [Related]
46. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
47. Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow "in situ tumor vaccination"?
Deplanque G; Shabafrouz K; Obeid M
Cancer Immunol Immunother; 2017 Jul; 66(7):833-840. PubMed ID: 28409192
[TBL] [Abstract][Full Text] [Related]
48. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Lee L; Matulonis U
Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
[TBL] [Abstract][Full Text] [Related]
49. Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia.
Chi MS; Mehta MP; Yang KL; Lai HC; Lin YC; Ko HL; Wang YS; Liao KW; Chi KH
Front Oncol; 2020; 10():254. PubMed ID: 32211319
[No Abstract] [Full Text] [Related]
50. Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade.
Zhao X; Shao C
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992835
[TBL] [Abstract][Full Text] [Related]
51. [Immunotherapy in head and neck squamous cell carcinoma : Abscopal effects in combination with radiotherapy, extraordinary responses in combination with chemotherapy, and pseudoprogression].
Brix N; Dunn L; Seiwert T; Belka C; Lauber K
Internist (Berl); 2020 Jul; 61(7):682-689. PubMed ID: 32462252
[TBL] [Abstract][Full Text] [Related]
52. Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite".
Arina A; Gutiontov SI; Weichselbaum RR
Clin Cancer Res; 2020 Jun; 26(12):2777-2782. PubMed ID: 32047000
[TBL] [Abstract][Full Text] [Related]
53. Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma.
Brenneman RJ; Sharifai N; Fischer-Valuck B; Hassanzadeh C; Guzelian J; Chrisinger JSA; Michalski JM; Oppelt P; Baumann BC
Front Oncol; 2019; 9():922. PubMed ID: 31616634
[No Abstract] [Full Text] [Related]
54. The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?
Hu ZI; McArthur HL; Ho AY
Curr Breast Cancer Rep; 2017; 9(1):45-51. PubMed ID: 28344743
[TBL] [Abstract][Full Text] [Related]
55. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
[TBL] [Abstract][Full Text] [Related]
56. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.
Rodríguez-Ruiz ME; Vanpouille-Box C; Melero I; Formenti SC; Demaria S
Trends Immunol; 2018 Aug; 39(8):644-655. PubMed ID: 30001871
[TBL] [Abstract][Full Text] [Related]
57. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.
Ji D; Song C; Li Y; Xia J; Wu Y; Jia J; Cui X; Yu S; Gu J
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106387
[TBL] [Abstract][Full Text] [Related]
58. Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
Trommer M; Yeo SY; Persigehl T; Bunck A; Grüll H; Schlaak M; Theurich S; von Bergwelt-Baildon M; Morgenthaler J; Herter JM; Celik E; Marnitz S; Baues C
Front Pharmacol; 2019; 10():511. PubMed ID: 31156434
[TBL] [Abstract][Full Text] [Related]
59. Immune modulation and stereotactic radiation: improving local and abscopal responses.
Zeng J; Harris TJ; Lim M; Drake CG; Tran PT
Biomed Res Int; 2013; 2013():658126. PubMed ID: 24324970
[TBL] [Abstract][Full Text] [Related]
60. Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations.
Karapetyan L; Iheagwara UK; Olson AC; Chmura SJ; Skinner HK; Luke JJ
J Natl Cancer Inst; 2023 Nov; 115(11):1278-1293. PubMed ID: 37348864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
